Lung Cancer Misdiagnosis Claims in Ireland: When a Delayed Diagnosis Becomes Negligence

What counts as lung cancer misdiagnosis under Irish law?

Lung cancer misdiagnosis under Irish law means a healthcare professional failed to detect, correctly identify, or appropriately act on lung cancer when a reasonably competent practitioner of the same specialist status would have done so. The legal test is the Dunne test from Dunne v National Maternity Hospital [1989] IR 91, reaffirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6. The claim does not require intent or recklessness. It requires proof that no reasonable peer would have made the same error in the same circumstances.

Lung cancer negligence in Ireland typically involves one of three failure points. The first is a primary care failure, where a GP treats persistent respiratory symptoms with repeated antibiotics or inhalers without ordering a chest X-ray or referring the patient to a Rapid Access Lung Clinic. The second is a radiology error, where a consultant radiologist fails to identify a solitary pulmonary nodule or suspicious opacity on imaging. The third is a systemic hospital failure, where an incidental finding on a scan ordered for an unrelated reason (a fall, a cardiac workup, a pre-operative assessment) is never followed up because nobody takes ownership of the abnormal result.

The State Claims Agency's national review of radiology claims (October 2023) confirmed these patterns with a specific lung cancer example: a 55-year-old patient with a persistent cough was referred for a chest X-ray that was reported as normal. Six months later, a repeat X-ray identified an abnormality in the right upper lobe. A CT scan confirmed lung cancer. Diagnostic errors accounted for 71% of all radiology claims reviewed, and 21% of missed-diagnosis claims involved cancer, with lung cancers missed on chest X-rays being the most common. A specific radiology mechanism behind many of these errors is called "satisfaction of search": when a radiologist identifies one abnormality on the image (a rib fracture, a pleural effusion), their attention shifts and the lung nodule goes undetected. According to a peer-reviewed study on missed lung cancer (Defined Imaging, 2017), roughly 90% of missed lung cancers occur on chest X-ray, and observer error, including satisfaction of search, accounts for a significant proportion. For a deeper analysis of radiology error types, see our radiology misdiagnosis claims page. The HSE's radiology archiving system (NIMIS) has also had documented flaws affecting report accuracy, a point covered in detail on our cancer misdiagnosis claims page.

A detail that catches many claimants off guard: the most common pattern in lung cancer negligence is not a GP ignoring symptoms. It is an incidental finding on a chest X-ray that nobody acts on. We call this the Diagnostic Gap Window, the measurable period between the point when the cancer should have been detected and the point when it actually was. Every month inside that window, the tumour advances, and each stage shift can be quantified using NCRI survival data.

How does the NCCP Rapid Access Lung Clinic pathway work?

The National Cancer Control Programme (NCCP) requires GPs to refer patients with red-flag lung cancer symptoms to a Rapid Access Lung Clinic (RALC) via the Healthlink electronic referral system, with a target of 95% of patients seen within 10 working days. According to the HSE/NCCP GP Referral Guidelines ^[4], the following symptoms trigger an urgent referral.

Unlike in England and Wales, where a two-week-wait urgent cancer referral system applies, Ireland's RALC pathway operates through Healthlink e-referral with a 10-working-day target. When a GP marks a referral as "routine" instead of "urgent" despite the presence of red-flag symptoms, or sends a letter rather than using the electronic pathway, the hospital may not triage it as urgent. That deviation from the NCCP standard is measurable and forms the foundation of a breach of duty argument.

There are Rapid Access Lung Clinics in eight designated cancer centres across Ireland, including St James's Hospital Dublin, St Vincent's University Hospital Dublin, Cork University Hospital, and Galway University Hospital. Once referred, the standard RALC pathway involves an initial assessment by a respiratory consultant, a CT thorax scan, a bronchoscopy or percutaneous biopsy if needed to confirm malignancy, followed by a multidisciplinary team (MDT) review and PET-CT staging if cancer is confirmed. According to a peer-reviewed study of the CUH RALC (2024), the average monthly referrals dropped significantly during COVID-19, from 57 to 42 per month. Referrals to lung RALCs nationally fell by 55% in January 2021 compared to January 2020, according to the Irish Cancer Society (February 2021). Patients whose referrals were delayed during that period and who are now presenting with advanced-stage disease may have viable claims if their GP failed to refer despite red-flag symptoms.

What conditions is lung cancer commonly mistaken for?

Lung cancer is one of the most frequently misdiagnosed cancers because its symptoms overlap with several common, non-cancerous respiratory conditions. In Ireland, 60% of lung cancer cases are diagnosed at a late stage, when treatment options are more limited, according to the RCSI (March 2025). One in four lung cancers in Ireland is first diagnosed through an emergency presentation, where a patient collapses or arrives at A&E with acute respiratory failure, according to the NCRI ^[3]. That high emergency rate frequently points to missed opportunities in primary care, where earlier, milder symptoms were dismissed or treated without imaging.

If your GP treated you for repeated chest infections, COPD exacerbations, or "post-viral cough" for months before a Stage III or IV lung cancer diagnosis, the question is whether a reasonably competent GP would have ordered imaging or referred you to a RALC earlier. The NCCP guidelines set clear thresholds for referral, and a GP who falls below them without documented clinical justification may have breached the duty of care.

Why chest X-rays miss lung cancer

A chest X-ray misses roughly 1 in 5 lung cancers that are present on the film at the time of imaging. A systematic review published in the British Journal of General Practice (2019) found that the sensitivity of chest X-ray for symptomatic lung cancer is only 77% to 80%. By contrast, low-dose CT scanning has a sensitivity of approximately 94%, according to the National Lung Screening Trial (NEJM, 2013). The gap between those two numbers is clinically significant and legally relevant.

Lung nodules are most commonly missed in what radiologists call the "blind zones": behind the heart, behind the mediastinum, below the diaphragm, at the lung apices, and overlapping the hilar structures where vessels and airways converge. Smaller nodules (under 1 cm) are particularly difficult to detect on a standard two-dimensional chest X-ray. A clear chest X-ray does NOT rule out lung cancer. If red-flag symptoms persist after a negative X-ray, the NCCP guidelines expect the GP to escalate to CT or refer directly to a RALC rather than reassure the patient and stop investigating.

Does your experience match a lung cancer negligence pattern?

Lung cancer negligence claims in Ireland typically fall into one of four patterns, based on where the NCCP clinical pathway ^[4] broke down. Select the scenario that most closely matches your experience to see the evidence path and likely claim type.

How does a delay change your lung cancer stage and survival?

The Diagnostic Gap Window is the measurable period between when your cancer should have been detected and when it actually was, and the TNM staging system quantifies the harm that delay caused. According to the NCRI (2024 Annual Report) ^[3], every month of delay allows the tumour to grow, potentially spread to lymph nodes or distant organs, and shift the cancer from a curable stage to a terminal one. The legal claim turns on proving that shift.

Proving causation in a lung cancer claim requires an independent oncology expert to answer a specific question: on the balance of probabilities, was the cancer present and detectable at the time of the alleged missed diagnosis, and if so, would earlier detection have changed the treatment pathway or prognosis? The expert must reconstruct the likely tumour size and stage at the earlier date, often using tumour doubling time calculations. Recent appellate decisions have highlighted the intensity with which Irish courts scrutinise this expert evidence. The Court of Appeal's decision in Crumlish v HSE underscored how forensic the battle over tumour doubling times becomes in oncology cases: the plaintiff's expert and the defence expert may reconstruct entirely different tumour sizes at the earlier date, leading to opposing conclusions about whether the cancer was detectable. The side with the more credible reconstruction typically wins the causation argument.

The difference between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) matters for this analysis. SCLC doubles in volume approximately every 30 days, meaning even a short delay can shift prognosis dramatically. NSCLC is slower growing, but the Diagnostic Gap Window calculation still applies. Your solicitor's choice of oncology expert must match the histological subtype of your cancer.

↑ Back to top

Who is liable when lung cancer is missed in an Irish hospital?

When lung cancer is missed in a public hospital in Ireland, the HSE is the defendant and the State Claims Agency (SCA) manages the claim under the Clinical Indemnity Scheme. The hospital and its doctors do not control the litigation once the SCA takes over. According to the State Claims Agency (2024), this is a centralised operation: the SCA instructs defence solicitors, appoints defence experts, and makes all settlement decisions.

If your lung cancer was missed by a private consultant, the defence is managed by their medical defence organisation (Medical Protection Society or Medical Defence Union). Where both a public hospital and a private consultant were involved (for example, a GP referred you to a public hospital where a radiologist missed the nodule), claims may proceed against multiple defendants.

The Supreme Court's ruling in Morrissey v HSE [2020] IESC 6 confirmed the HSE's non-delegable duty of care. The HSE remains primarily liable even when care was delivered through contracted laboratories or outsourced radiology services. If your chest X-ray was read by an outsourced radiology provider who missed a lung nodule, the HSE cannot escape liability by pointing to the contractor.

Can you claim if you never smoked?

Yes. Smoking status does not determine whether you have a valid lung cancer misdiagnosis claim in Ireland. The NCCP GP Referral Guidelines ^[4] list red-flag symptoms that require urgent RALC referral regardless of smoking history. The legal test is whether the GP or specialist met the standard of care, not whether you fit the "typical" patient profile. Never-smokers face a specific risk: GPs are less likely to consider lung cancer as a differential diagnosis, which paradoxically makes negligence more likely, not less.

Radon exposure is the second largest cause of lung cancer in Ireland after smoking. According to the Environmental Protection Agency (2024), approximately 350 lung cancer cases in Ireland each year are linked to radon. The EPA's 2022 revised maps estimate 170,000 homes are at risk, with Waterford, Cork, and counties along the western seaboard showing the highest concentrations. If you are a never-smoker diagnosed with lung cancer and you live in a high-radon area, the question for negligence is whether your GP adequately investigated your symptoms or dismissed them because "you don't smoke."

One aspect the official guidance does not cover: the defence in a never-smoker case will argue that the GP's lower index of suspicion was reasonable given the absence of smoking history. Your expert must show that the NCCP guidelines do not limit referral criteria to smokers. The red-flag symptoms (haemoptysis, persistent cough, unexplained weight loss) apply regardless of smoking status.

What evidence proves your lung cancer was missed?

The core evidence in a lung cancer misdiagnosis claim is the original imaging (chest X-rays, CT scans) compared against the later diagnostic imaging by an independent radiology expert. Your solicitor will request all medical records, including the original DICOM image files from the HSE's NIMIS (National Integrated Medical Imaging System) archive, not just the written reports.

The practical evidence checklist for a lung cancer claim includes: all GP consultation notes showing when you first reported symptoms and what the GP did, all radiology images and reports (including any scans taken for unrelated reasons), the RALC referral form (or evidence that no referral was made), the pathology report confirming cancer type and stage, and the oncology treatment records showing what treatment was required at the point of actual diagnosis versus what would have been needed at the earlier date.

The timing matters more than people expect: request your medical records early. Under the Data Protection Act 2018, you are entitled to copies of your records. Hospital imaging is stored digitally, but GP handwritten notes may be harder to retrieve. If your GP has retired or the practice has closed, records may have been transferred to a successor practice or to the HSE.

The evidence strategy depends on which type of failure occurred. If the radiologist misread the scan entirely (a perception error), your expert will compare the original DICOM images against the later diagnostic imaging to show the nodule was visible at the earlier date. If the radiologist correctly identified the nodule and recommended follow-up but nobody scheduled it, the evidence shifts to the hospital communication trail: the original report, the GP or consultant who received it, and the absence of any recall letter or follow-up appointment in the patient record. These are different claim types requiring different expert reports and, in some cases, different defendants.

One detail that surprises clients: since September 2024, hospitals are legally required to disclose certain patient safety incidents under the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023. If the hospital has already identified the missed lung cancer through an internal review or SCA risk-management process, that disclosure can become early evidence in your claim before you even engage a solicitor.

How long do you have to claim for lung cancer misdiagnosis?

The limitation period for lung cancer misdiagnosis claims in Ireland is two years from your date of knowledge, not from the date of the original missed scan or failed referral. Under the Statute of Limitations 1957 ^[5] (as amended by the 1991 Act), the clock starts on the date you knew, or ought reasonably to have known, that you suffered an injury attributable to another person's negligence.

Unlike in England and Wales, where a three-year limitation applies to clinical negligence claims, Ireland's two-year limit is shorter and stricter. This distinction is critical for anyone reading UK-based content about lung cancer claims: the UK timeframe does not apply in the Republic of Ireland.

If you are a lung cancer patient whose chest X-ray nodule was missed in 2022 but who was not correctly diagnosed until 2025 when a follow-up scan revealed Stage III disease, your date of knowledge is likely 2025, when you first learned that the cancer was attributable to the earlier missed finding. The defence may argue you "ought to have known" earlier based on your worsening symptoms. Establishing the correct date of knowledge often requires expert evidence and can itself be contested in court.

For children, the two-year period does not begin until the child turns 18. A parent or guardian can bring a claim at any time before the child reaches adulthood.

What compensation can you expect for lung cancer negligence?

Compensation for lung cancer misdiagnosis in Ireland is assessed under the Judicial Council Personal Injuries Guidelines (2021) for general damages, combined with special damages covering all quantifiable financial losses. Awards vary case by case and depend on the severity of the stage shift, the treatment required, and the impact on your life expectancy and quality of life.

General damages compensate for pain, suffering, and loss of amenity. In cases where a delay shifted the diagnosis from a curable stage to a terminal one, general damages reflect the loss of life expectancy, the additional suffering from more aggressive treatment (chemotherapy and radiotherapy instead of surgery alone), and the psychological impact of a terminal diagnosis that could have been avoided.

Special damages in lung cancer claims are often substantial. They cover past and future loss of earnings, the cost of additional medical treatment (including private oncology, immunotherapy, and targeted therapies), travel costs to cancer centres, home adaptations for patients with respiratory failure, and the cost of professional care. In fatal cases, special damages include the future care costs that would have been incurred had the patient survived, as well as dependency claims by the deceased's family.

↑ Back to summary

What if the patient has died from lung cancer?

Dependants can bring a fatal injury claim under the Civil Liability Act 1961 for the financial loss caused by the death, plus a solatium payment capped at a total of €35,000 shared among all dependants. Lung cancer is the leading cause of cancer death in Ireland, and a significant proportion of lung cancer negligence claims involve fatal outcomes.

The solatium cap is often a shock to families. The €35,000 is not per person. It is a total figure divided among the surviving spouse, children, and any other qualifying dependants. The real financial value in a fatal claim comes from the dependency calculation: the court assesses the financial support the deceased would have provided to their dependants over their projected remaining working life, adjusted for the probability that the negligence shortened that life.

The High Court ruling in Germaine v Day [2024] IEHC 420 addressed a claim by a widow who suffered psychiatric injury from watching her husband's gradual decline from a delayed lung cancer diagnosis caused by a misread chest X-ray. The court applied the Kelly v Hennessy criteria and held that witnessing a loved one's gradual deterioration, while undeniably traumatic, does not constitute the "sudden shock" required for a secondary victim nervous shock claim under current Irish law. Families should be aware of this limitation before pursuing a psychiatric injury claim alongside the dependency claim.

How does the claims process work in Ireland?

Lung cancer misdiagnosis claims in Ireland are exempt from the Injuries Resolution Board (IRB), formerly PIAB, under s.3(d) of the PIAB Act 2003 and proceed directly through the High Court. The process begins with collecting your full medical records, including all imaging, and instructing an independent oncology and radiology expert to assess breach of duty and causation.

The typical stages are: records collection (3 to 6 months), independent expert reports (6 to 12 months after records received), a pre-litigation letter under s.8 Civil Liability and Courts Act 2004, then proceedings issued in the High Court. Under the HC131 and HC132 Practice Directions effective from April 2025, expert evidence must be exchanged early and mediation is strongly encouraged before trial. The SCA's published data shows approximately 43% of clinical negligence claims concluded in 2024 were resolved through mediation. The average Irish medical negligence claim takes approximately 1,462 days (roughly four years), according to the Medical Protection Society (2024).

Between assessment and settlement, the sticking point is usually causation. The defence in a lung cancer claim will typically concede that the scan was misread (breach) but contest whether earlier detection would have changed the outcome. Your oncology expert must prove, on the balance of probabilities, that the stage shift reduced your treatment options or survival prospects. The causation question in lung cancer is more contested than in most other medical negligence claims because tumour biology varies by subtype and individual.

↑ Top of page

What to consider next

If your lung cancer was diagnosed at an advanced stage and you believe symptoms or scan findings were missed earlier, the first step is to request your full medical records, including all imaging. Do this before contacting a solicitor, if you can, because the records take time to arrive. If the limitation clock is tight, contact us first and we will request the records in parallel.

If a family member has died from lung cancer and you suspect a delayed diagnosis, the estate or dependants can bring a claim. The two-year limitation applies from the date of death if the deceased had not already commenced proceedings. Start by gathering the death certificate, all hospital and GP records, and any correspondence about the diagnosis timeline.

If you are unsure whether the delay in your case is enough to support a claim, the Diagnostic Gap Window analysis is what your solicitor and expert will use to answer that question. A short delay with no stage shift may not support a claim. A delay of months that shifted the diagnosis from Stage I to Stage III almost certainly will.

Call 01 903 6408 for a no-obligation case review.

Related questions about lung cancer claims in Ireland

What if the radiologist identified the nodule but nobody recalled me?

The duty to act on a radiology finding rests with both the reporting radiologist and the clinician who ordered the scan. If the radiologist flagged the nodule in the report but the referring doctor or hospital administration failed to recall you, the negligence may lie with the referrer rather than the radiologist. Both can be named as defendants, and the SCA will manage the claim if it involves a public hospital.

Can I claim if the cancer was ultimately terminal regardless of timing?

Potentially. Even when earlier detection would not have prevented death, the claim can address the "lost years" of life expectancy, the avoidance of more aggressive treatment, and the loss of a period of higher-quality life. Irish courts assess what treatment would have been available at the earlier stage and whether it would have extended the patient's life or reduced suffering.

Do I need a UK-based expert for a lung cancer claim in Ireland?

In most cases, yes. Independent expert oncologists and radiologists in Irish lung cancer negligence claims are typically sourced from the UK because the small size of the Irish medical community creates conflicts of interest. Your solicitor will instruct an expert of equivalent specialist status to the practitioner being assessed, as the Dunne test requires.

References

Sources cited above, accessed March 2026.

1. Dunne v National Maternity Hospital [1989] IR 91. BAILII
2. Morrissey v HSE [2020] IESC 6. BAILII
3. National Cancer Registry Ireland. Cancer in Ireland 1994-2022: Annual Statistical Report (2024). NCRI
4. NCCP Lung Cancer Rapid Access Service GP Referral Guidelines. HSE
5. Statute of Limitations 1957. Irish Statute Book
6. PIAB Act 2003, s.3(d). Revised Acts
7. Environmental Protection Agency. Radon and Health Risks. EPA
8. State Claims Agency. Clinical Indemnity Scheme. SCA
9. Judicial Council. Personal Injuries Guidelines (2021). Judicial Council
10. Civil Liability Act 1961. Revised Acts
11. Germaine v Day [2024] IEHC 420. Courts Service
12. RCSI. Landmark Lung Health Check (March 2025). RCSI
13. Civil Liability and Courts Act 2004, s.8. Irish Statute Book
14. Irish Cancer Society. RALC referral concerns (Feb 2021). ICS
15. State Claims Agency. Learning from radiology claims (October 2023). SCA
16. Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (Act No. 10). Irish Statute Book
17. Lung Cancer in the Republic of Ireland. Journal of Thoracic Oncology, 2023. ScienceDirect
18. Bradley SH et al. Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. British Journal of General Practice, 2019. PubMed
19. National Lung Screening Trial Research Team. Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer. NEJM, 2013. NEJM
20. del Ciello A et al. Missed lung cancer: when, where, and why? Diagnostic and Interventional Radiology, 2017. PMC